Suppr超能文献

精神分裂症严重程度 BPRS-6 量表的临床计量学分析。

A clinimetric analysis of a BPRS-6 scale for schizophrenia severity.

机构信息

1Psychiatric Research Unit,Psychiatric Centre North Zealand,Copenhagen University Hospital,Hillerød,Denmark.

2Vanderbilt University,Nashville,Tennessee,USA.

出版信息

Acta Neuropsychiatr. 2018 Aug;30(4):187-191. doi: 10.1017/neu.2017.40. Epub 2018 Feb 7.

Abstract

OBJECTIVE

A restricted Brief Psychiatric Rating Scale (BPRS-6) with the six schizophrenia specific items from the Positive and Negative Syndrome Scale (PANSS) has been investigated. These six items from the PANSS have recently been found to have both clinical validity and 'unidimensionality' in measuring the severity of schizophrenic states. The primary objective of this study was to evaluate the clinical validity of the BPRS-6. The secondary objective was to evaluate the 'unidimensionality' of the BPRS-6 by an 'item response theory' model.

METHODS

The BPRS-6 was scored independently by two psychiatrists and two psychologists while viewing six open-ended videotaped interviews in patients with a DSM-III diagnosis of schizophrenia. The interviews were conducted by Heinz E. Lehmann, an experienced psychiatrist. They were focused on the psychopathology that contributed most to the 'severity' of the patient's clinical state.

RESULTS

The BPRS-6 with three positive symptoms (delusions, conceptual disorganisation, hallucinations) and three negative symptoms (blunted affect, emotional withdrawal, poverty of speech) was found to be clinically valid and captured the variables that contribute most to the severity of schizophrenia. The BPRS-6 was also found to have acceptable 'unidimensionality' (coefficient of homogeneity 0.45) and inter-rater reliability (inter-class-coefficient 0.81).

CONCLUSION

The BPRS-6 was found to capture the information that translates into the severity of schizophrenia. It has also acceptable psychometric validity.

摘要

目的

研究了一种限制的Brief 精神病评定量表(BPRS-6),其中包含来自阳性和阴性综合征量表(PANSS)的六个特定于精神分裂症的项目。这些来自 PANSS 的六个项目最近被发现具有临床有效性和“单维性”,可用于衡量精神分裂症状态的严重程度。本研究的主要目的是评估 BPRS-6 的临床有效性。次要目的是通过“项目反应理论”模型评估 BPRS-6 的“单维性”。

方法

两位精神科医生和两位心理学家在观看六位接受 DSM-III 诊断为精神分裂症的患者的开放式录像访谈时,独立对 BPRS-6 进行评分。访谈由经验丰富的精神病学家 Heinz E. Lehmann 进行。他们专注于导致患者临床状态“严重程度”的精神病理学。

结果

发现 BPRS-6 具有三个阳性症状(妄想、概念混乱、幻觉)和三个阴性症状(情感迟钝、情感退缩、言语贫乏),具有临床有效性,并捕捉到了导致精神分裂症严重程度的主要变量。BPRS-6 还具有可接受的“单维性”(同质性系数 0.45)和评分者间可靠性(组内相关系数 0.81)。

结论

BPRS-6 被发现能够捕捉到转化为精神分裂症严重程度的信息。它也具有可接受的心理测量有效性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验